Welcome To E-Poster Presentations
Click Return To Home to navigate back to the first page
Return To Home
E-Presentation
Refresh Page
View All
Pathological heterogeneity as a prognostic factor in patients with advanced renal cell carcinoma receiving sorafenib
Paper No: 448 | Oncology - Renal Tumours
Lina Wang
Back to Top
